The publication of this infographic was supported by Shionogi.
In Europe, Fetcroja® (Cefiderocol) is indicated for the treatment of infections due to aerobic Gram-negative organisms in adults with limited treatment options. Consideration should be given to official guidance on the appropriate use of antibacterial agents. The label may differ in other countries; please check local prescribing information. Please access the full Fetcroja® Summary of Product Characteristics here. Adverse Events Reporting information can be found at the bottom of this infographic.
